Charles A. Schiffer
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 217
- Acute Myeloid Leukemia Research 119
- Chronic Myeloid Leukemia Treatments 75
- Hematopoietic Stem Cell Transplantation 33
- Genetics 106
- Chronic Lymphocytic Leukemia Research 84
- Co-authors
- Richard A. Larson (34 shared papers)Clara D. Bloomfield (34 shared papers)Bayard L. Powell (17 shared papers)Peter H. Wiernik (37 shared papers)Richard M. Stone (24 shared papers)Robert J. Mayer (15 shared papers)Frederick R. Appelbaum (14 shared papers)Deborah Berg (6 shared papers)
- Journals
- Blood (58 papers)Journal of Clinical Oncology (35 papers)American Journal of Hematology (15 papers)Transfusion (13 papers)Leukemia Research (13 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Charles A. Schiffer
274 papers receiving 21.3k citations
Charles A. Schiffer's Hit Papers
Peers
Comparison fields: 5 of 156
- Hematology 15.5k
- Genetics 6.5k
- Biochemistry 1.3k
- Oncology 4.4k
- Public Health, Environmental and Occupational Health 4.5k
Countries citing papers authored by Charles A. Schiffer
This map shows the geographic impact of Charles A. Schiffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles A. Schiffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles A. Schiffer more than expected).
Fields of papers citing papers by Charles A. Schiffer
This network shows the impact of papers produced by Charles A. Schiffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles A. Schiffer. The network helps show where Charles A. Schiffer may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles A. Schiffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 280 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia Hit paper breakdown → | 2003 | 1873 |
| 2 | Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia Hit paper breakdown → | 2002 | 1517 |
| 3 | Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B Hit paper breakdown → | 2002 | 1326 |
| 4 | Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia Hit paper breakdown → | 1994 | 1027 |
| 5 | All-trans-Retinoic Acid in Acute Promyelocytic Leukemia Hit paper breakdown → | 1997 | 806 |
| 6 | Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia Hit paper breakdown → | 2000 | 754 |
| 7 | 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines Hit paper breakdown → | 2000 | 629 |
| 8 | Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. Hit paper breakdown → | 1990 | 617 |
| 9 | Report of an international working group to standardize response criteria for myelodysplastic syndromes. Hit paper breakdown → | 2000 | 524 |
| 10 | Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Hit paper breakdown → | 1998 | 508 |
| 11 | 2001 | 399 | |
| 12 | Acute myeloid leukaemia in adults Hit paper breakdown → | 2013 | 397 |
| 13 | 1995 | 335 | |
| 14 | 1988 | 326 | |
| 15 | 2002 | 324 | |
| 16 | 2007 | 308 | |
| 17 | 1999 | 281 | |
| 18 | 2002 | 271 | |
| 19 | 2005 | 265 | |
| 20 | 2013 | 244 |
About Charles A. Schiffer
Charles A. Schiffer is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Molecular Biology and Oncology, having authored 280 papers that have together received 22.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (119 papers), Chronic Lymphocytic Leukemia Research (84 papers), Chronic Myeloid Leukemia Treatments (75 papers), Acute Lymphoblastic Leukemia research (60 papers), Hematopoietic Stem Cell Transplantation (33 papers), Blood transfusion and management (31 papers), Neutropenia and Cancer Infections (28 papers) and Eosinophilic Disorders and Syndromes (24 papers). The work is most often cited by research in Hematology (15.5k citations), Genetics (6.5k citations), Biochemistry (1.3k citations), Oncology (4.4k citations) and Public Health, Environmental and Occupational Health (4.5k citations). Charles A. Schiffer has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Richard A. Larson, Clara D. Bloomfield, Bayard L. Powell, Peter H. Wiernik, Richard M. Stone, Robert J. Mayer, Frederick R. Appelbaum, Deborah Berg, Bercedis L. Peterson and Martin S. Tallman. Their work appears in journals such as Blood, Journal of Clinical Oncology, American Journal of Hematology, Transfusion and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.